Nanopath

About:

Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.

Website: https://www.nanopathdx.com/

Twitter/X: nanopathdx

Top Investors: Alumni Ventures, National Science Foundation, Norwest Venture Partners, National Institutes of Health, Green D Ventures

Description:

Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.

Total Funding Amount:

$14.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2019-01-01

Founders:

Alison Burklund, Amogha Tadimety

Number of Employees:

11-50

Last Funding Date:

2024-05-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai